XenoSTARTBreast cancerCDK4/6 inhibitorsendocrine therapyCDK 4/6 inhibitorsWorld Health OrganizationCDK4/6
…cer types were obtained and analyzed from models established by XenoSTART. In the ST940C model originating from an ER+/HER2+ breast cance…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…cer types were obtained and analyzed from models established by XenoSTART. In the ST940C model originating from an ER+/HER2+ breast cance…
…cer types were obtained and analyzed from models established by XenoSTART. In the ST940C model originating from an ER+/HER2+ breast cance…
… 97 breast cancer patient-derived xenografts (PDX), supplied by XenoSTART, were analyzed for 11q13 gene fusions. WES data were evaluated …